Sort by
Refine Your Search
-
risk factor for a variety of mental health disorders, including depression, anxiety, eating disorders, substance use, and personality disorders. Around 10% of the general population have problematically
-
complete their milestone 1 within 6 month of enrolment and remain enrolled on a full time basis for the duration of the scholarship. Enquiries The PhD supervisory team will involve a composition of some of
-
engagement component of the scholarship will include an industry placement with Intergrain (Bibra Lake, Western Australia). A suitable candidate can start in January 2025. Student type Current Students Future
-
questionnaire. Twelve months after dissemination of the material, all households will be sent a follow-up questionnaire. We will randomly select n=20 people (n=10 from each location and stratified by sex), who
-
Class [2A] designation, or hold a master’s degree with a substantial research / thesis component. Existing qualifications must be in Marketing, Services management or a Cognate discipline.. Relevant work
-
CSIRO Undertake an Industry Engagement component with the industry partner Seek approval for Personal Leave longer than that outlined in the Commonwealth Scholarships Guidelines (Research) 2017 from
-
Australian police custody and young people. The project is a component of Dr Shelley Walker’s Australian Research Council (ARC) Discovery Early Career Research Award (#DE240101056 ). The National Drug Research
-
focussed on supporting a student to work on cutting edge research in collaboration with Kurloo and CSIRO with a pathway to commercialisation of the research outcomes. The industry engagement component of
-
also not be in receipt of any other scholarship. Essential: English language IELTS level of 7 and above Essential: Successful completion of an Honours or Masters programme with a research component (or
-
HH pathway element Smoothened (Smo) in a way that differs from cyclopamine and other Smo inhibitors. However, its limited water solubility impedes achieving adequate drug concentrations across